Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04205799
Title Cabozantinib for Advanced or Metastatic Cervical Carcinoma After Platinum Treatment Failure (CABOCOL-01)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Centre Francois Baclesse
Indications

cervical squamous cell carcinoma

cervical adenosquamous carcinoma

cervical adenocarcinoma

Therapies

Cabozantinib

Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.